Avzivi

Avzivi (Bevacizumab) is an intravenous medication used to treat certain types of cancer. It works by targeting and inhibiting the growth of blood vessels that supply tumors, helping to slow or stop cancer progression.

Avzivi is primarily used in the treatment of various cancers, including colorectal, lung, kidney, and cervical cancers. It is often used in combination with other chemotherapy drugs to enhance their effectiveness. The medication works by blocking a protein called vascular endothelial growth factor (VEGF), which is involved in the formation of new blood vessels that tumors need to grow.

Common effects of Avzivi may include high blood pressure, fatigue, and changes in appetite. Some patients may also experience nausea, vomiting, or diarrhea. It is important to discuss any persistent or severe side effects with a healthcare provider.

Avzivi should be administered under the supervision of a healthcare professional. It is important to inform your doctor about any existing medical conditions, especially if you have a history of high blood pressure, heart problems, or bleeding disorders. Regular monitoring may be required during treatment.

Avzivi may interact with other medications, including those that affect blood clotting or the immune system. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol consumption should be discussed with your doctor.